Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Makanga, C. Dewachter, B. Rondelet, R. Naeije, L. Dewachter (Brussels, Belgium). Downregulated BMPR2 signaling pathway in nitrofen-induced pulmonary hypoplasia. Eur Respir J 2011; 38: Suppl. 55, 4306

Member's Comments

No comment yet.

Related content which might interest you: Involvement of the Hedgehog signalling pathway in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011 Defective p53-mediated pro-apoptotic pathway in idiopathic pulmonary fibrosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Increased pulmonary Wnt signaling in patients with sarcoidosis Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties Year: 2007 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Hypoxia-induced miR-130a is a novel repressor of BMPR2 gene expression in experimental pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 mTOR signalling is an essential pathway for TGF-β1 induced collagen synthesis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis Source: Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019 Year: 2020 Imbalanced expression of the type I TGF-beta receptors ALK-1 in pulmonary fibrosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Selective TSC1 deletion in smooth muscle activates mTOR signaling and induces pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Decreased expression of the TGF-beta type I receptor ALK1 in pulmonary arterial hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Bone morphogenetic protein signaling in experimental nitrofen-induced congenital diaphragmatic hernia Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Imbalanced type I TGF-β receptor signalling in the pulmonary vasculature: implications for the pathogenesis of bronchopulmonary dysplasia Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 YI02 - Activation of Wnt/beta-catenin signaling promotes lung epithelial repair in emphysema Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Endothelial control of BMPR2 signalling in experimental shunt-induced pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Dysregulation of the TGF-beta system in idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 10s Year: 2004 Wnt signalling and parenchymal fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Heterozygous SOD2 deletion deteriorated chronic intermittent hypoxia-induced lung inflammation and vascular remodeling through mtROS-NLRP3 signaling pathway Source: Virtual Congress 2020 – New insights into sleep apnoea: from diagnosis to treatment Year: 2020